Nantahala Capital Management’s Cogentix Medical, Inc. CGNT Stock Holding History

Nantahala Capital Management’s Portfolio CGNT Stock Details CGNT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q2	–	Sell	-3,639,853	Closed	-$14M	–	93
2018 Q1	$14M	Hold	3,639,853	–	–	0.63%	40
2017 Q4	$11.5M	Hold	3,639,853	–	–	0.51%	40
2017 Q3	$9.32M	Buy	3,639,853 +5,588	+0.2%	+$12.2K	0.46%	37
2017 Q2	$6.32M	Buy	3,634,265 +271,270	+8%	+$465K	0.5%	36
2017 Q1	$6.19M	Buy	3,362,995 +230,611	+7%	+$456K	0.69%	31
2016 Q4	$6.3M	Sell	3,132,384 -192,493	-6%	-$393K	0.65%	34
2016 Q3	$6.05M	Buy	3,324,877 +189,921	+6%	+$246K	0.73%	33
2016 Q2	$3.02M	Buy	3,134,956 +643,652	+26%	+$635K	0.33%	48
2016 Q1	$2.74M	Sell	2,491,304 -103,462	-4%	-$116K	0.28%	52
2015 Q4	$3.35M	Buy	2,594,766 +1,308,976	+102%	+$1.79M	0.44%	48
2015 Q3	$1.52M	Buy	1,285,790 +479,843	+60%	+$736K	0.21%	59
2015 Q2	$1.31M	Buy	+805,947	New	+$1.32M	0.19%	64

Nantahala Capital Management's CGNT Position: Q2 2018 in Review

Nantahala Capital Management sold out of Cogentix Medical, Inc. (CGNT) in Q2 2018, closing a stake of 3,639,853 shares — an estimated $14M sold.

Nantahala Capital Management first reported a position in CGNT in Q2 2015 and held it in 12 quarters. The position peaked at $14M in Q1 2018. 0 funds tracked by Wall St. Rank hold CGNT as of Q2 2018.

Nantahala Capital Management reported no remaining Cogentix Medical, Inc. position as of Q2 2018 after selling out during the quarter.
Nantahala Capital Management sold 3,639,853 Cogentix Medical, Inc. shares in Q2 2018, an estimated $14M.
Nantahala Capital Management first reported a position in Cogentix Medical, Inc. in Q2 2015 and held it in 12 quarters.
Nantahala Capital Management's Cogentix Medical, Inc. position peaked at $14M in Q1 2018.
0 funds tracked by Wall St. Rank held Cogentix Medical, Inc. as of Q2 2018.

Based on Nantahala Capital Management's 13F filing for Q2 2018, filed 14 Aug 2018.